Pervasis Therapeutics Named to Red Herring 100, Spring 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pervasis Therapeutics, Inc., a pioneer in regenerative cell-based therapies and technologies, today announced that it has been named a recipient of the Red Herring 100 Spring 2007, an award given to the top 100 private technology companies based in North America.
MORE ON THIS TOPIC